AzTrials
AzTrials

Fragile X Associated Tremor-ataxia SyndromeFXTASNCT04428567

Treadmill Training in Fragile X-associated Tremor/Ataxia Syndrome

A study testing Dual-Task Treadmill exercise + Cognitive Training in people with Fragile X Associated Tremor-ataxia Syndrome, run by Rush University Medical Center at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

A pilot trial to determine the feasibility of treadmill training with dual training in patients with Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS). Read more about this study

Who is it for?
Ages 50 years and older
What is being tested?
Dual-Task Treadmill exercise + Cognitive Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3 participants
Where
1 siteUnited States
Study dates
30 Jul 2019to 30 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • A diagnosis of possible, probable or definite FXTAS
  • Able to stand and walk without support for 2 minutes

Who cannot join

  • Any neurologic or musculoskeletal problems
  • History of traumatic brain injury
  • Significant cardiopulmonary or cardiovascular disease
  • Dementia or other significant cognitive impairment
  • Unstable psychiatric disorders

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Kellogg Building 1625 W. Harrison St. Room 235

    Chicago, Illinois, 60612

Other trials in United States

About this study

Official title: A Pilot Dual-Task Treadmill Training to Improve Gait and Balance in Fragile X-Associated Tremor/Ataxia Syndrome

A pilot trial to determine the feasibility of treadmill training with dual training in patients with Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).

Read the detailed description

There is substantial evidence that physical exercise can improve motor and cognitive function in individuals with Parkinson's Disease, traumatic brain injury or chronic stroke survivors. However, to the investigator's knowledge, no studies have explored the effect of treadmill training with or without a cognitive dual Task on gait, balance and cognition in Fragile X - Associated Tremor/Ataxia Syndrome (FXTAS), which is characterized by action tremor, cerebellar gait ataxia, parkinsonism, peripheral neuropathy and cognitive deficits, all of which increase the risk for falls and progressive disability. There are presently no medications or treatment interventions that have been shown to effectively manage the symptoms of FXTAS or delay disease progression, and it is currently not clear whether either the ST or Dual-Task treadmill training paradigms would be feasible or effective in FXTAS.

A total of 10 individuals with FXTAS will recruited from the Rush University Movement Disorders Clinic or the FXTAS Clinic Database at Rush University. The subjects will be assigned to either 6 weeks of dual-task treadmill exercise training combined with a cognitive task (intervention group) occurring 3 times weekly, or control group. The primary outcome measures will be feasibility, safety and patient adherence. The assessments will occur at baseline, week 3, week 6, 1 month \& 6 month post-training.

Being tested
Dual-Task Treadmill exercise + Cognitive Training
Keywords
Dual-task, feasibility, FXTAS, treadmill training
Medical subject headings
Fragile X Tremor Ataxia Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dual-Task Treadmill exercise + Cognitive TrainingBehavioural

    The dual-task regimen will include treadmill exercise of 5-10 min warm-up and cool-down, 30 minutes of running towards target heart rate, combined with respond demands with the addition of cognitive tasks. The level of duration and intensity of treadmill exercise will progressively increase over the duration of 6 weeks.

Study groups in NCT04428567
Study groupRoleWhat they receive
Treadmill Exercise + Cognitive Training (Dual-Task)ExperimentalThe Dual-Task group will be provided with treadmill training with added simultaneous cognitive training during treadmill exercise training.
Receives: Behavioral: Dual-Task Treadmill exercise + Cognitive Training
Control GroupNo interventionThe control group will be assessed as the intervention group at the same time intervals without the intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. High levels of program attendance, and retention

    At each study visit the subjects attend and revisit were taken down throughout the entire intervention period in an attendance/retention log book.

    Measured: 6 weeks

  2. High levels of satisfaction

    At the end of the entire study a client satisfaction questionnaire was administered and interpreted based on a percent of satisfaction, ranging from zero to one hundred percent, on various satisfactory questions. Zero percent meaning highly unsatisfied and one hundred percent meaning highly satisfied.

    Measured: 6 weeks

  3. High levels of recruitment

    Research subjects were recruited using a recruitment flyer for the study and tracked by the number of willing participants.

    Measured: 6 months

Secondary outcomes (15)
  1. Change in balance and mobility measured by Instrumented-SWAY (i-SWAY)

    A test (not a scale) to assess balance and postural sway. Subjects will be asked to stand still with their hands across their chests and their feet positioned a set distance apart (scaled to their height) with a wearable sensor that records movements applied to the lumbar trunk. This sensor will record parameters including mean total sway area, path length, jerk, and sway distance in the mediolateral and anteroposterior directions.

    Measured: 6 weeks

  2. Change in functional mobility measured by Instrumented-WALK (i-WALK)

    A test to examine fatigue over time and that will also allow more accurate calculation of gait variability indices by increasing the number of steps. The subject will walk 25 meters, turn and walk back, and repeat this until 2 minutes has elapsed.

    Measured: 6 weeks

  3. Change in balance and mobility measured by Mini-BEST balance scale

    This is a shortened version of the Balance Evaluation systems Test (BESTest). It aims to target and identify 6 different balance control systems and has been used as a performance-based balance measure in many interventions and clinical trials. 1) The original BESTest 4 level (0-3) scoring was revised to 3 levels (0-2) due to redundancy. 2) Total Score = 28 points per test directions. 3) Two items have right and left assessment in which the lower score is used within the total score (directions specify which to use). 4) For research, many studies specify use of both left and right data, thus calculating data based on 32 (vs 28 points).

    Measured: 6 weeks

  4. Change in patient reported confidence in balance measured by Activities-Specific Balance Confidence Scale (ABC)

    A 16-item self-report questionnaire in which patients rate their balance confidence for performing activities. Items are rated on a rating scale that ranges from 0 - 100. Score of zero represents no confidence, a score of 100 represents complete confidence. Overall score is calculated by adding item scores and then dividing by the total number of items.

    Measured: baseline, week 6, post-training month 1 & month 6

  5. Change in cognitive function measured by the Montreal Cognitive ASsessment (MoCa)

    A screening instrument designed to help health professionals detect mild cognitive dysfunction. Subjects will answer questions to measure different areas of cognition including attention and concentration, executive functions, memory, language, visuo-constructional skills, conceptual thinking, calculations, and orientation. MoCA scores range between 0 and 30. A score of 26 or over is considered to be normal.

    Measured: 6 months

  6. Change in cognitive function measured by the Symbol Digit Modalities Test (SDMT)

    A test for evaluating information processing speed, and the subject uses a reference key to pair specific numbers with given abstract geometric figures in 90 seconds. Scores are the correct number of pairs made in 90 seconds, with greater scores indicating greater cognitive abilities.

    Measured: 6 weeks

  7. Change in cognitive function measured by Controlled Oral Word Association Test (COWAT)

    A phonemic test for verbal fluency and verbal memory. The COWAT uses the three letter set of C, F, and L to assess phonemic fluency. Subjects will be given 1 min to name as many words as possible beginning with one of the letters.

    Measured: 6 weeks

  8. Change in cognitive function measured by (STROOP)

    A neuro-psychological test for attention and response inhibition the assess the ability to inhibit cognitive interference while processing a specific stimulus.

    Measured: 6 weeks

  9. Change in cognitive function measured by Digit Span forward and backward test

    One of the oldest and most widely used test of short-term verbal and working memory. On each trial subjects will be presented with a series of digits appearing one at a time on a computer screen. Subjects will be tested in 2 variants; forward-span and backward-span. In the forward-span, the subject will be asked to recall the digits in the order they appeared. In the backward-span, subjects will be asked to recall the digits in the reverse order they appeared.

    Measured: 6 weeks

  10. Change in health related quality of life measured by the Neuro Quality of Life Survey

    Neuro-QoL (Quality of Life in Neurological Disorders) is a measurement system that evaluates and monitors the physical, mental, and social effects experienced by adults and children living with neurological conditions. It is a self-report of health related quality of life in 17 domains and sub-domains for adults and 11 for children with neurological disorders. Raw scores are converted based on consistent metric (T-distribution) with data from the US general population with a t-score mean of 50 and standard deviation of 10. Adult Banks include 19-45 items. Items are scored on a 5-point scale that uses different language depending on assessment. the questions range from least (1) to most (5) based on frequency of behavior, amount of difficulty, or degree of agreement.

    Measured: 6 months

  11. Change in depression measured by the Center for Epidemiologic Studies Depression Scale (CES-D)

    The CES-D is a brief self-report measure that assesses symptoms of depression in the general population. It is a 20-item, self-report measure designed to be used in the general population that assess current symptoms of depression (i.e. this week). The standard cut-off score suggesting depression >16.

    Measured: 6 weeks

  12. Change in quality of sleep measured by the Pittsburgh Sleep Quality Index (PSQI) questionnaire

    The PSQI is an effective instrument used to measure the quality and patterns of sleep in adults. it differentiates "poor" from "good" sleep quality by measuring seven different areas over the last month; 19 self-reported items belongs to one of seven subcategories: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Five additional questions rated by the respondent's roommate or bed partner are included for clinical purposes and are not scored.

    Measured: 6 weeks

  13. Change in perceived exertion on physical activity intensity measured by the Borg Rating Scale (Borg Rating of Perceived Exertion Scale)

    The Borg Rating of Perceived Exertion Scale measures physical activity intensity felt by the participant based on the physical sensations a participant experiences during physical activity, including increased heart rate, increased respiration or breathing rate, increased sweating, and muscle fatigue.It is a 20-point scale with verbal descriptors to standardize perceived exertion across tasks and individuals. a score of 0 = nothing at all to 10 = very hard.

    Measured: 6 weeks

  14. Change in physical activity level measured step counts monitored by Fitbit wrist watch

    The daily steps counts monitored by Fitbit wristband will be used as the measure of physical activity

    Measured: 6 weeks

  15. Change in anxiety measured by the Beck Anxiety Inventory (BAI).

    The BAI is a self-report measure of anxiety that assesses anxiety symptoms and symptom severity. The BAI can discriminate anxiety from depression. 4-point Likert scale response for anxiety symptoms are severity within a week; the total score is calculated by calculating the sum of 21 items. Minimum score of 0 and a maximum score of 63. Score Interpretation: 0-7 = minimal anxiety; 8-15 = mild anxiety; 16-25 = moderate anxiety; 26-63 = severe anxiety

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2020
  2. Study start30 Jul 2019
  3. Primary completion30 Mar 2020
  4. Study completion30 Mar 2020

Why it stopped: Due to COVID 19, the recruitment was halted.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
The subjects will be randomly assigned to 2 groups: 1) treadmill training group with a cognitive task (Intervention group) 2) Control group. The entire intervention period is 6 weeks in both groups, with interventional training occurring 3 days per week for approximately 45 minutes per session. Evaluations will take place at baseline, 3 weeks, at the end of 6 weeks, and 1 month and 6 months after the intervention.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
3 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04428567
Sponsor's protocol ID
18200205
Acronym
FXTAS
Status last verified
Oct 2021
First submitted
1 Oct 2019
Last updated
28 Oct 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Dual-Task Treadmill exercise + Cognitive Training in people with Fragile X Associated Tremor-ataxia Syndrome, run by Rush University Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 28 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Due to COVID 19, the recruitment was halted.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

High levels of program attendance, and retention (time frame: 6 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in